Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of ReShape Lifesciences Inc. from Q4 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
ReShape Lifesciences Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2013 to Q3 2025.
  • ReShape Lifesciences Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 30, 2025 was $3.92M.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)

ReShape Lifesciences Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.92M +$8M Sep 30, 2025 10-Q 2025-11-14
Q2 2025 -$4.99M -$1.02M -25.7% Jun 30, 2025 10-Q 2025-11-14
Q1 2025 -$4.69M +$1.62M +25.7% Mar 31, 2025 10-Q 2025-11-14
Q4 2024 -$4.39M +$1.78M +28.9% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 -$4.09M Sep 30, 2024 10-Q 2025-11-14
Q2 2024 -$3.97M Jun 30, 2024 10-Q 2025-11-14
Q1 2024 -$6.3M Mar 31, 2024 10-Q 2025-11-14
Q4 2023 -$6.17M Dec 31, 2023 10-Q 2025-11-14
Q1 2021 $10.1M -$974K -8.8% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $4.67M -$11.2M -70.6% Dec 31, 2020 10-Q 2021-05-12
Q3 2020 $5.92M -$14.1M -70.5% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $7.18M -$1.2M -14.3% Jun 30, 2020 10-Q 2020-11-06
Q1 2020 $11.1M +$4.55M +69.9% Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $15.8M +$2.74M +20.9% Dec 31, 2019 10-Q 2021-05-12
Q3 2019 $20.1M Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $8.38M -$7.68M -47.8% Jun 30, 2019 10-Q 2020-11-06
Q1 2019 $6.52M -$17.9M -73.3% Mar 31, 2019 10-Q 2020-11-06
Q4 2018 $13.1M -$22M -62.7% Dec 31, 2018 10-K 2021-03-12
Q2 2018 $16.1M Jun 30, 2018 10-Q 2019-07-24
Q1 2018 $24.4M Mar 31, 2018 10-Q 2019-07-24
Q4 2017 $35.1M -$29.2M -45.4% Dec 31, 2017 10-K 2020-02-27
Q4 2016 $64.3M +$119M Dec 31, 2016 10-K 2019-02-22
Q4 2015 -$55.1M -$15.3M -38.3% Dec 31, 2015 10-K 2018-03-05
Q4 2014 -$39.9M -$9.69M -32.1% Dec 31, 2014 10-K 2018-03-05
Q4 2013 -$30.2M Dec 31, 2013 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.